Botanical Drug Development Roundtable
The Reagan-Udall Foundation for the FDA, in collaboration with the FDA's Center for Drug Evaluation and Research, convened an invitation only roundtable to:
- Identify current challenges in botanical drug development
- Explore opportunities to accelerate the development of botanical drug products in the United States
Our Learnings from Expert Discussions summary, capturing the insights from this roundtable, is now available.